Analysts forecast Brown & Brown’s fourth-quarter earnings per share to reach $0.89, a 3.5% increase compared with the same period last year. Revenue is projected at $1.65 billion, up 35.8% year-over-year, reflecting robust renewal and net new business growth. Improved investment income and higher premium volume are cited as key drivers, while organic revenue growth is expected to bolster overall results when the company reports on January 26, 2026.

In the quarter, Brown & Brown launched its National Healthcare Practice, branded Brown & Brown Healthcare, consolidating over 140 specialists to deliver risk and insurance solutions tailored to healthcare organizations. This unit aims to expand market access for clients, develop competitive program offerings and manage billions in premiums globally, supporting hundreds of hospitals, medical groups and provider networks.

The board declared a quarterly cash dividend of $0.165 per share, payable on February 11, 2026 to shareholders of record February 4. Key balance-sheet metrics include a debt-to-equity ratio of 0.64, reflecting a conservative leverage profile, and a current ratio of 1.18, indicating sufficient liquidity to meet short-term obligations. Price-to-earnings and price-to-sales ratios stand at approximately 26.05 and 5.04, respectively, underscoring investor valuation levels.

Founded in 1939, Brown & Brown is a leading global insurance brokerage firm with over 700 locations and more than 23,000 employees. The firm specializes in customized property and casualty, employee benefits, personal risk and specialty insurance products. Its extensive branch network and professional team support scalable growth strategies and client retention across commercial, public sector and personal lines segments.